Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Virology

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.1999.0093PMID 10648178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles

  1998cited by this paper
• The effect of epitope variation on the profile of cytotoxic T lymphocyte responses to the HIV envelope glycoprotein.

  1998cited by this paper
• Gene vaccination: plasmid DNA is more than just a blueprint.

  1998cited by this paper
• Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.

  1998cited by this paper
• Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

  1998cited by this paper
• The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis.

  1998cited by this paper
• The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

  1998cited by this paper
• Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

  1998cited by this paper
• Identification of Replication-Competent Strains of Simian Immunodeficiency Virus Lacking Multiple Attachment Sites for N-Linked Carbohydrates in Variable Regions 1 and 2 of the Surface Envelope Protein

  1998cited by this paper
• Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations.

  1998cited by this paper
• Biologically erodable microspheres as potential oral drug delivery systems

  1997cited by this paper
• MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.

  1997cited by this paper
• Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.

  1997cited by this paper
• Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin.

  1997cited by this paper
• Nucleic acid vaccines: an overview.

  1997cited by this paper
• Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

  1997cited by this paper
• Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).

  1996cited by this paper
• Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?

  1996cited by this paper
• Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

  1996cited by this paper
• Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities

  1994cited by this paper
• Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia?

  1994cited by this paper
• Potential of polymer microencapsulation technology for vaccine innovation.

  1994cited by this paper
• Mucosal immunity, HIV transmission, and AIDS.

  1993cited by this paper
• Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses

  1991cited by this paper
• Biodegradable microspheres as a vaccine delivery system.

  1991cited by this paper
• In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment.

  1990cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper
• Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus

  1989cited by this paper
• Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.

  1989cited by this paper
• New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

  1983cited by this paper
• Vaccinia virus: a selectable eukaryotic cloning and expression vector.

  1982cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper
• Design and analysis of factorial experiments.

  1962cited by this paper

• Chitosan-based Oral DNA vaccine elicits mucosal immunity and reduces Helicobacter pylori colonization in mice.

  2025cites this paper
• The role of engineered materials in mucosal vaccination strategies

  2023cites this paper
• Advancement in Polymer-Based Carrier for DNA Vaccine.

  2023cites this paper
• Mucosal vaccine delivery: A focus on the breakthrough of specific barriers

  2022cites this paper
• A brief review on DNA vaccines in the era of COVID-19

  2021cites this paper
• Oral Biologic Delivery: Advances Towards Oral Subunit, DNA and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

  2020cites this paper
• miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

  2019cites this paper
• Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

  2018cites this paper
• Oral Non-Viral Gene Delivery for Applications in DNA Vaccination and Gene Therapy.

  2018cites this paper
• Hericium erinaceus polysaccharide facilitates restoration of injured intestinal mucosal immunity in Muscovy duck reovirus-infected Muscovy ducklings.

  2018cites this paper
• Polymers for DNA Vaccine Delivery.

  2017cites this paper
• Chitosan‐zein nano‐in‐microparticles capable of mediating in vivo transgene expression following oral delivery

  2017cites this paper
• Nanostructures for oral delivery of therapeutic nucleic acids

  2017cites this paper
• Assessment of Anti–HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different Populations

  2016cites this paper
• Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines.

  2016cites this paper
• DNA Vaccines for the Induction of Immune Responses in Mucosal Tissues

  2015cites this paper
• Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.

  2015cites this paper
• Induction of Intestinal Immunity by Mucosal Vaccines As a Means of Controlling HIV Infection

  2014cites this paper
• Oral Vaccination: Attenuated and Gene-Based

  2013cites this paper
• A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

  2013cites this paper
• Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination.

  2012cites this paper
• Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant

  2012cites this paper
• Pharmaceutical Non-Viral Formulations for Gene Vaccines

  2012cites this paper
• Technologies for enhanced efficacy of DNA vaccines

  2012cites this paper
• Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.

  2012cites this paper
• T Cell-Biased Immune Responses Generated by a Mucosally-targeted Adenovirus-Sigma 1 Vaccine

  2012cites this paper
• Gene Delivery Using Chemical Methods

  2011cites this paper
• Progress Towards a Needle-Free Hepatitis B Vaccine

  2011cites this paper
• Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models.

  2011cites this paper
• ZEIN NANOSPHERES FOR GENE DELIVERY

  2011cites this paper
• Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.

  2011cites this paper
• HIV Infection and Specific Mucosal Immunity

  2011cites this paper
• Mucosal HIV vaccines: a holy grail or a dud?

  2010cites this paper
• NON-CONDENSING POLYMERIC GENE DELIVERY SYSTEMS: PRINCIPLES AND APPLICATIONS

  2010cites this paper
• Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines

  2010cites this paper
• Induction of virus-specific cell-mediated cytotoxic responses of isogeneic ginbuna crucian carp, after oral immunization with inactivated virus.

  2010cites this paper
• Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.

  2010cites this paper
• Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes

  2010cites this paper
• WITHDRAWN: Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal models

  2010cites this paper
• Naked DNA Vaccines

  2010cites this paper
• Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

  2010cites this paper
• RETRACTED: Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal models

  2009cites this paper
• DETERMINATION OF THE PERMEABILITY OF BIOLOGICAL MEMBRANES TO VARIOUS CHEMICAL MARKERS, INCLUDING ANTI-HIV DRUGS

  2009cites this paper
• Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.

  2009cites this paper
• Construction of sperm-specific lactate dehydrogenase DNA vaccine and experimental study of its immunocontraceptive effect on mice

  2008cites this paper
• Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

  2007cites this paper
• Optimization of an FaeG DNA vaccine in pigs

  2007cites this paper
• Polymeric nano- and microparticle technologies for oral gene delivery

  2007cites this paper
• Oral vaccination: where we are?

  2007cites this paper
• Progress towards an AIDS mucosal vaccine: an overview.

  2007cites this paper
• Molecular design of functional polymers for gene therapy

  2007cites this paper
• Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.

  2007cites this paper
• Delivery systems and adjuvants for oral vaccines

  2006cites this paper
• Microparticles and DNA Vaccines

  2006influential citation
• Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.

  2005cites this paper
• DNA Vaccines for Mucosal Immunity to Infectious Diseases

  2005cites this paper
• Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.

  2005cites this paper
• Exploiting receptor biology for oral vaccination with biodegradable particulates.

  2005cites this paper
• Construction, Characterization and Immunogenicity of Human Immunodeficiency Virus-Like Particles

  2005cites this paper
• Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.

  2004cites this paper
• Mucosal HIV vaccines: where are we now?

  2004cites this paper
• Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.

  2004cites this paper
• Mucosal AIDS vaccines: current status and future directions

  2004cites this paper
• Formulation of a microparticle carrier for oral polyplex-based DNA vaccines.

  2004cites this paper
• Orally delivered malaria vaccines: not too hard to swallow

  2004cites this paper
• Microparticles for the delivery of DNA vaccines

  2004cites this paper
• Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine.

  2004cites this paper
• Human Immunodeficiency Virus Type 1 Gag-Specific Mucosal Immunity after Oral Immunization with Papillomavirus Pseudoviruses Encoding Gag

  2004cites this paper
• Combined Vaccine Regimen Based on Parenteral Priming with a DNA Vaccine and Administration of an Oral Booster Consisting of a Recombinant Salmonella enterica Serovar Typhimurium Vaccine Strain for Immunization against Infection with Human-Derived Enterotoxigenic Escherichia coli Strains

  2004cites this paper
• DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration

  2004cites this paper
• Approaches to Enhance the Efficacy of DNA Vaccines

  2004cites this paper
• From Microbiology and Tumor Biology Center (MTC), Karolinska Institutet and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

  2004cites this paper
• Humoral Mucosal and Systemic Immunity Results in Long-Term HIV-1 Neutralizing Prime-Boost Immunization Regimen in Mice Intranasal HIV-1-gp160-DNA/gp41 Peptide

  2004cites this paper
• Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity1

  2004cites this paper
• Concepts in DNA immunization overcoming viral diversity and enhancing plasmid immunogenicity

  2004cites this paper
• Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

  2004cites this paper
• Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice.

  2003cites this paper
• Microparticles and nanoparticles as delivery systems for DNA vaccines.

  2003cites this paper
• The role of mucosal immunity in prevention of HIV transmission.

  2003cites this paper
• The Gene Pill and its therapeutic applications.

  2003cites this paper
• Oral Plasmid DNA Delivery Systems for Genetic Immunisation

  2003cites this paper
• Mucosal AIDS Vaccines

  2003cites this paper
• Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1.

  2003cites this paper
• Mucosal immunization with DNA vaccines.

  2003cites this paper
• New generation of mucosal adjuvants for the induction of protective immunity

  2003cites this paper
• Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors

  2003cites this paper
• Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.

  2003cites this paper
• Advances in oral vaccine delivery options

  2003cites this paper
• Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles.

  2002cites this paper
• Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein.

  2002cites this paper
• Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

  2002cites this paper
• Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity.

  2002cites this paper
• HIV Vaccines Design and Development

  2002cites this paper
• Cytokines as adjuvants for HIV DNA vaccines

  2002cites this paper
• Successful Boosting of a DNA Measles Immunization with an Oral Plant-Derived Measles Virus Vaccine

  2002cites this paper
• The Development of Polyplex-based DNA Vaccines

  2002cites this paper
• Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.

  2001cites this paper
• Update on Antiviral DNA Vaccine Research (1998–2000)

  2001cites this paper
• Innovations in oral gene delivery: challenges and potentials.

  2001cites this paper
• Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.

  2001cites this paper